Around four million people in the UK carry genetic variants that protect them from obesity, type 2 diabetes and heart disease, suggests new research. The team say the discovery could lead to the development of new drugs that help people lose weight.
Scientists have known for several years that genes can influence a person's weight. One of the genes that is known to play a key role in regulating weight is MC4R, which codes for the melanocortin 4 receptor. This receptor acts like a switch in the brain to suppress appetite. People who have genetic variants that disrupt this receptor gain weight easily.
Now, in a study published in the journal Cell, researchers have shown that other genetic variants in the MC4R gene that increase the activity of this brain receptor can protect people from becoming overweight, a finding that could lead to the development of new medicines that 'copy' the protective effect of these genetic variants to achieve or maintain weight-loss.
A team looked at the MC4R gene in half a million volunteers from the UK population who have taken part in the UK Biobank study, finding 61 distinct naturally-occurring genetic variants. While some of these genetic variants predisposed people to become obese, other variants provided protection against obesity and some of its major complications, such as type 2 diabetes and heart disease.
To investigate the reasons for this mystery, the team, who previously showed that MC4R works in the brain as a 'switch' to tell us to stop eating after a meal, studied the function of these genetic variants in a number of laboratory experiments. They found that MC4R gene variants linked to higher obesity risk stopped the gene from working, whereas variants that offered protection against obesity kept the gene 'switched on'.
Around six per cent of study participants carried genetic variants that caused the receptor to remain 'switched on'. People with these variants would eat less, which could explain their lower weight. People with two copies of these particular variants (1 in over 1,000 people) were on average 2.5 kg lighter than people without the variants and had a 50% lower risk of type 2 diabetes and heart disease.
"This study drives home the fact that genetics plays a major role in why some people are obese - and that some people are fortunate enough to have genes that protect them from obesity," says the senior author.
The discovery adds to recent work by the team which showed that some slim people have a genetic advantage when it comes to maintaining their weight.
"It doesn't mean that we can't influence our weight by watching what we eat, but it does mean the odds are stacked against some people and in favour of others," added the senior author.
When the researchers looked in detail at the genetic variants in laboratory experiments, they found that MC4R can send signals through a pathway - known as the beta-arrestin pathway - that had not previously been linked to weight regulation. Genetic variants that sent signals preferentially through this pathway were the ones driving the association with protection against obesity and its complications and, importantly, were also associated with lower blood pressure. Designing drugs that mimic the effect of the protective variants in MC4R could provide new, safer weight loss therapies.
"A powerful emerging concept is that genetic variants that protect against disease can be used as models for the development of medicines that are more effective and safer," said the joint lead author of the study. "Our findings may pave the way for a new generation of weight loss therapies that activate MC4R preferentially via the beta-arrestin pathway."
"Genetic studies of thousands of people and a functional understanding of the mechanisms behind protective genetic variants can really help us inform the development of a new generation of medicines for common diseases like obesity and diabetes that affect millions of people globally."
https://www.cam.ac.uk/research/news/discovery-of-genetic-variants-that-protect-against-obesity-and-type-2-diabetes-could-lead-to-new
https://www.cell.com/cell/fulltext/S0092-8674(19)30345-9
Latest News
Psychosocial experiences ar…
By newseditor
Posted 25 Jun
How a microbe and a prebiot…
By newseditor
Posted 24 Jun
Slowing inflammation may bo…
By newseditor
Posted 24 Jun
Cellular senescence in norm…
By newseditor
Posted 24 Jun
Neuronal communication capt…
By newseditor
Posted 24 Jun
Other Top Stories
Neighboring cells inhibit regeneration of aged intestinal epithelium
Read more
Seizures in Alzheimer's disrupt adult neurogenesis
Read more
Making transplanted stem cells stick around and do their jobs
Read more
A transcription factor keeps breast stem cells healthy by promoting…
Read more
Muscle loss with menopause explained!
Read more
Protocols
Deciphering spatial domains…
By newseditor
Posted 23 Jun
High-throughput volumetric…
By newseditor
Posted 21 Jun
Bioengineered human colon o…
By newseditor
Posted 14 Jun
Development of an efficient…
By newseditor
Posted 12 Jun
A co-culture system of macr…
By newseditor
Posted 10 Jun
Publications
An unexpected role for the…
By newseditor
Posted 25 Jun
Coordinated action of a gut…
By newseditor
Posted 25 Jun
Safety of non-replicative a…
By newseditor
Posted 25 Jun
Arabidopsis CaLB1 undergoes…
By newseditor
Posted 25 Jun
Cellular senescence in norm…
By newseditor
Posted 24 Jun
Presentations
Myelin plasticity in the ve…
By newseditor
Posted 10 Jun
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar